When paired with analysis software, data generated from next-generation sequencing (NGS) can inform patient care as well as guide public health and hospital infection control strategies. Ongoing technological advances and continued studies are making the tool more accessible for clinical laboratories. “NGS possesses immense value in contributing to the clinical utility within the healthcare setting,” says author and bioMérieux expert Stephen Vella, PhD. 

Stephen Vella, PhD, Medical Science Liaison at bioMérieux

Medical Laboratory Observer
May 18, 2022